When Reversible Ligands Do Not Reverse, and Other Modelers' Dilemmas

被引：1
作者：
Slifstein, Mark [1 ,2 ]
机构：
[1] Columbia Univ, New York, NY 10032 USA
[2] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2010年 / 51卷 / 07期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; SEROTONIN TRANSPORTER OCCUPANCY; HISTAMINE H-3 RECEPTOR; BRAIN; F-18; PET; SCHIZOPHRENIA; QUANTITATION; VALIDATION; INFUSION;
D O I：
10.2967/jnumed.109.073445
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：1005 / 1008
页数：4
相关论文
共 28 条
  • [1] Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia
    Arakawa, Ryosuke
    Ito, Hiroshi
    Takano, Akihiro
    Takahashi, Hidehiko
    Morimoto, Takuya
    Sassa, Takeshi
    Ohta, Katsuya
    Kato, Motoichiro
    Okubo, Yoshiro
    Suhara, Tetsuya
    [J]. PSYCHOPHARMACOLOGY, 2008, 197 (02) : 229 - 235
  • [2] Evaluation of 11C-GSK189254 as a Novel Radioligand for the H3 Receptor in Humans Using PET
    Ashworth, Sharon
    Rabiner, Eugenii A.
    Gunn, Roger N.
    Plisson, Christophe
    Wilson, Alan A.
    Comley, Robert A.
    Lai, Robert Y. K.
    Gee, Antony D.
    Laruelle, Marc
    Cunningham, Vincent J.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (07) : 1021 - 1029
  • [3] COMPARISON OF BOLUS AND INFUSION METHODS FOR RECEPTOR QUANTITATION - APPLICATION TO [F-18] CYCLOFOXY AND POSITRON EMISSION TOMOGRAPHY
    CARSON, RE
    CHANNING, MA
    BLASBERG, RG
    DUNN, BB
    COHEN, RM
    RICE, KC
    HERSCOVITCH, P
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (01) : 24 - 42
  • [4] Histamine H3 receptor antagonists reach out for the clinic
    Celanire, S
    Wijtmans, M
    Talaga, P
    Leurs, R
    de Esch, IJP
    [J]. DRUG DISCOVERY TODAY, 2005, 10 (23-24) : 1613 - 1627
  • [5] Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited
    Cunningham, Vincent J.
    Rabiner, Eugenii A.
    Slifstein, Mark
    Laruelle, Marc
    Gunn, Roger N.
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2010, 30 (01) : 46 - 50
  • [6] FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71
  • [7] Evaluation of the binding characteristics of [18F]fluoroproxyfan in the rat brain for in vivo visualization of histamine H3 receptor
    Funaki, Yoshihito
    Sato, Kimihiko
    Kato, Motohisa
    Ishikawa, Yolchi
    Iwata, Ren
    Yanai, Kazuhiko
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2007, 34 (08) : 981 - 987
  • [8] The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia
    Gründer, G
    Landvogt, C
    Vernaleken, I
    Buchholz, HG
    Ondracek, J
    Siessmeier, T
    Härtter, S
    Schreckenberger, M
    Stoeter, P
    Hiemke, C
    Rösch, F
    Wong, DF
    Bartenstein, P
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 (05) : 1027 - 1035
  • [9] Inverse Agonist Histamine H3 Receptor PET Tracers Labelled With Carbon-11 or Fluorine-18
    Hamill, Terence G.
    Sato, Nagaaki
    Jitsuoka, Makoto
    Tokita, Shigeru
    Sanabria, Sandra
    Eng, Waisi
    Ryan, Christine
    Krause, Stephen
    Takenaga, Norihiro
    Patel, Shil
    Zeng, Zhizhen
    Williams, David, Jr.
    Sur, Cyrille
    Hargreaves, Richard
    Burns, H. Donald
    [J]. SYNAPSE, 2009, 63 (12) : 1122 - 1132
  • [10] Hargreaves R, 2002, J CLIN PSYCHIAT, V63, P18
123